"2019 was a rewarding year for Sobi in which we made major progress in every area of our strategy. We ended the year as a stronger company with a broader geographical footprint and exceptional value in both our on-market and pre-market portfolios," says
Sobi's 2019 Annual and Sustainability Report is available on www.sobi.com as a pdf and an online version.
About Sobi™
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, Sobi employs approximately 1,400 people across
For more information please contact
Paula Treutiger, Head of Communication & Investor Relations
+ 46 733 666 599
paula.treutiger@sobi.com
+ 46 708 734 095
linda.holmstrom@sobi.com
Postal address SE-112 76
Phone: 46 8 697 20 00 www.sobi.com
https://news.cision.com/swedish-orphan-biovitrum-ab/r/sobi--publishes-2019-annual-and-sustainability-report,c3083326
https://mb.cision.com/Main/14266/3083326/1225974.pdf
(c) 2020 Cision. All rights reserved., source